Correction to: Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM

Lina Mörén,Richard Perryman,Tim Crook,Julia K. Langer,Kevin Oneill,Nelofer Syed,Henrik Antti

BMC Cancer（2018）

引用 2|浏览10

暂无评分

摘要

In the original publication of this article [1], published on 8 February 2018, it was noticed that the acknowledgement of the source of the drug ADI-PEG20 was missing.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要